Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride

被引:57
作者
Whitson, Jess T. [1 ]
Cavanagh, H. Dwight [1 ]
Lakshman, Neema [1 ]
Petroll, W. Matthew [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA
关键词
glaucoma; cornea; benzalkonium chloride; preservative;
D O I
10.1007/BF02850305
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The corneal toxicity of 2 intraocular pressure-lowering agents was compared in a rabbit cornea model with New Zealand White rabbits. Corneal epithelial morphology and cell size were assessed by in vivo confocal microscopy. Baseline microscopic examinations were performed on 1 eye of each animal. Two weeks later, the eyes were bathed for 3 min in travoprost 0.004% preserved without benzalkonium chloride (BAK) or latanoprost 0.005% preserved with 0.02% BAK; the eyes were then rinsed with balanced salt solution, and the corneas were again examined by confocal microscopy (n=4/group). A second group of animals was exposed to the medications through a dosing regimen of 1 drop/min (3 drops total) (n=4/group). in eyes treated with travoprost without BAK (3-min bath), superficial epithelial cells were similar to baseline, as indicated by their visible cell borders and bright nuclei. In contrast, the surface cells in eyes treated with latanoprost were significantly smaller and brighter and had less distinct borders. Surface cell size was significantly smaller as compared with baseline size and as compared with rabbits treated with travoprost without BAK for 3 min. Similar effects on corneal epithelial cell morphology were observed with the 1-drop/min dosing regimen. in this rabbit model, travoprost 0.004% preserved without BAK did not cause corneal epithelial toxicity; latanoprost 0.005% induced superficial cell loss, most likely caused by the presence of a relatively high concentration of BAK (0.02%).
引用
收藏
页码:663 / 671
页数:9
相关论文
共 20 条
  • [1] Baudouin C, 1996, Curr Opin Ophthalmol, V7, P80, DOI 10.1097/00055735-199604000-00014
  • [2] Ocular surface inflammatory changes induced by topical antiglaucoma drugs -: Human and animal studies
    Baudouin, C
    Pisella, PJ
    Fillacier, K
    Goldschild, M
    Becquet, F
    De Saint Jean, M
    Béchetoille, A
    [J]. OPHTHALMOLOGY, 1999, 106 (03) : 556 - 563
  • [3] Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers
    Baudouin, C
    de Lunardo, C
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (01) : 39 - 42
  • [4] Allergic reaction to topical eyedrops
    Baudouin, C
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 5 (05) : 459 - 463
  • [5] Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface
    Becquet, F
    Goldschild, M
    Moldovan, MS
    Ettaiche, M
    Gastaud, P
    Baudouin, C
    [J]. CURRENT EYE RESEARCH, 1998, 17 (04) : 419 - 425
  • [6] ADVERSE-EFFECTS OF TOPICAL ANTIGLAUCOMATOUS MEDICATIONS ON THE CONJUNCTIVA
    BRAODWAY, D
    GRIERSON, I
    HITCHINGS, R
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (09) : 590 - 596
  • [7] ADVERSE-EFFECTS OF TOPICAL ANTIGLAUCOMA MEDICATION .2. THE OUTCOME OF FILTRATION SURGERY
    BROADWAY, DC
    GRIERSON, I
    OBRIEN, C
    HITCHINGS, RA
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (11) : 1446 - 1454
  • [8] FISHER AA, 1987, CUTIS, V39, P381
  • [9] GOBBELS M, 1992, OPHTHALMOLOGY, V99, P873
  • [10] In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells
    Guenoun, JM
    Baudouin, C
    Rat, P
    Pauly, A
    Warnet, JM
    Brignole-Baudouin, O
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (07) : 2444 - 2450